Titre :

Effect of adrenaline dose on neurological outcome in out-of-hospital cardiac arrest: a nationwide propensity score analysis.

Auteur(s) :

Jaeger, D. [Auteur]
Centre Hospitalier Régional Universitaire de Nancy [CHRU Nancy]
Défaillance Cardiovasculaire Aiguë et Chronique [DCAC]
Canon, Valentine [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Javaudin, F. [Auteur]
Centre Hospitalier Universitaire de Nantes = Nantes University Hospital [CHU Nantes]
Debaty, G. [Auteur]
Centre Hospitalier Universitaire [CHU Grenoble] [CHUGA]
Duhem, H. [Auteur]
Centre Hospitalier Universitaire [CHU Grenoble] [CHUGA]
Koger, J. [Auteur]
Centre Hospitalier Universitaire de Nancy [CHU Nancy]
Gueugniaud, Pierre-Yves [Auteur]
Hospices Civils de Lyon [HCL]
Tazarourte, K. [Auteur]
Research on Healthcare Performance [RESHAPE - Inserm U1290 - UCBL1]
El Khoury, C. [Auteur]
Hubert, Hervé [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Chouihed, T. [Auteur]
Défaillance Cardiovasculaire Aiguë et Chronique [DCAC]

Titre de la revue :

European Journal of Emergency Medicine

Nom court de la revue :

Eur J Emerg Med

Numéro :

29

Pagination :

p. 63-69

Date de publication :

2022-02

ISSN :

1473-5695

Mot(s)-clé(s) en anglais :

adrenaline
advanced life support
out-of-hospital cardiac arrest
resuscitation

Discipline(s) HAL :

Sciences du Vivant [q-bio]

Résumé en anglais : [en]

Background Adrenaline is recommended during cardio-pulmonary resuscitation. The optimal dose remains debated, and the effect of lower than recommended dose is unknown. Objective To compare the outcome of patients ...
Lire la suite >Background Adrenaline is recommended during cardio-pulmonary resuscitation. The optimal dose remains debated, and the effect of lower than recommended dose is unknown. Objective To compare the outcome of patients treated with the recommended, lower or higher cumulative doses of adrenaline. Design, settings, participants Patients were included from the French National Cardiac Arrest Registry and were grouped based on the received dose of adrenaline: recommended, higher and lower dose. Outcome measures and analysis The primary endpoint was good neurologic outcome at 30 days post-OHCA, defined by a cerebral performance category (CPC) of less than 3. Secondary endpoints included return of spontaneous circulation and survival to hospital discharge. A multiple propensity score adjustment approach was performed. Main results 27 309 patients included from July 1st 2011 to January 1st 2019 were analysed, mean age was 68 (57–78) years and 11.2% had ventricular fibrillation. 588 (2.2%) patients survived with a good CPC score. After adjustment, patients in the high dose group had a significant lower rate of good neurologic outcome (OR, 0.6; 95% CI, 0.5–0.7). There was no significant difference for the primary endpoint in the lower dose group (OR, 0.8; 95% CI, 0.7–1.1). There was a lower rate of survival to hospital discharge in the high-dose group vs. standard group (OR, 0.5; 95% CI, 0.5–0.6). Conclusion The use of lower doses of adrenaline was not associated with a significant difference on survival good neurologic outcomes at D30. But a higher dose of adrenaline was associated with a lower rate of survival with good neurological outcomes and poorer survival at D30.Lire moins >

Langue :

Anglais

Audience :

Internationale

Vulgarisation :

Non

Établissement(s) :

Université de Lille
CHU Lille

Collections :

• METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694

Date de dépôt :

2023-11-15T05:21:16Z
2024-02-22T09:59:28Z